14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:CERC
Delisted

Cerecor Inc. Stock Price (Quote)

$0.319
+0.0060 (+1.92%)
At Close: May 27, 2022

Range Low Price High Price Comment
30 days $141.16 $183.01 Friday, 27th May 2022 CERC stock ended at $0.319. This is 1.92% more than the trading day before Thursday, 26th May 2022. During the day the stock fluctuated 9.33% from a day low at $0.300 to a day high of $0.328.
90 days $141.16 $227.30
52 weeks $84.73 $227.30

Historical Cerecor Inc. prices

Date Open High Low Close Volume
Jun 02, 2021 $2.78 $2.89 $2.77 $2.81 595 397
Jun 01, 2021 $2.65 $2.89 $2.63 $2.78 876 662
May 28, 2021 $2.68 $2.74 $2.63 $2.64 618 786
May 27, 2021 $2.67 $2.70 $2.60 $2.62 579 106
May 26, 2021 $2.61 $2.68 $2.59 $2.66 467 386
May 25, 2021 $2.61 $2.67 $2.56 $2.59 769 860
May 24, 2021 $2.60 $2.74 $2.57 $2.58 951 750
May 21, 2021 $2.74 $2.74 $2.55 $2.63 1 020 879
May 20, 2021 $2.54 $2.70 $2.50 $2.70 1 391 781
May 19, 2021 $2.38 $2.59 $2.36 $2.59 2 795 908
May 18, 2021 $2.18 $2.39 $2.17 $2.27 953 817
May 17, 2021 $2.18 $2.27 $2.13 $2.23 598 693
May 14, 2021 $2.25 $2.27 $2.09 $2.20 1 178 253
May 13, 2021 $2.38 $2.38 $2.06 $2.25 2 215 105
May 12, 2021 $2.47 $2.52 $2.31 $2.36 3 681 769
May 11, 2021 $2.89 $3.30 $2.41 $2.61 69 107 083
May 10, 2021 $2.69 $2.72 $2.51 $2.54 430 087
May 07, 2021 $2.78 $2.81 $2.64 $2.72 304 778
May 06, 2021 $2.75 $2.78 $2.63 $2.76 477 981
May 05, 2021 $2.92 $2.95 $2.78 $2.80 322 646
May 04, 2021 $3.16 $3.16 $2.90 $2.91 466 821
May 03, 2021 $3.17 $3.20 $2.99 $3.09 706 441
Apr 30, 2021 $2.70 $3.17 $2.69 $3.14 1 214 063
Apr 29, 2021 $2.88 $2.91 $2.69 $2.78 365 327
Apr 28, 2021 $2.90 $2.91 $2.72 $2.85 678 822
Click to get the best stock tips daily for free!

About Cerecor Inc.

Cerecor. Cerecor Inc., a clinical-stage biopharmaceutical company, develops drugs to treat patients with neurological and psychiatric disorders. It develops CERC-301 that is in Phase II development stage for the adjunctive treatment of patients with major depressive disorder (MDD); CERC-501, which is in Phase II development stage for the adjunctive treatment of MDD, as well as to treat substance use disorders; and CERC-406 that is in preclinical stage to ... CERC Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT